These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1469186)

  • 1. Ciprofloxacin levels in a patient undergoing veno-venous haemodiafiltration.
    Barrie JR; Mousdale S
    Intensive Care Med; 1992; 18(7):437-8. PubMed ID: 1469186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann ChJ
    Acta Med Austriaca; 2002; 29(3):112-6. PubMed ID: 12168566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A service evaluation comparing CVVH an CVVHD in minimising circuit failure.
    Ede J; Dale A
    Nurs Crit Care; 2017 Jan; 22(1):52-57. PubMed ID: 26871268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage of intravenous ciprofloxacin.
    Dibble JB; Acomb C; Campbell L; White LO; Brownjohn AM
    J Antimicrob Chemother; 1987 Sep; 20(3):454-6. PubMed ID: 3680084
    [No Abstract]   [Full Text] [Related]  

  • 7. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
    Davenport A
    Contrib Nephrol; 2004; 144():317-28. PubMed ID: 15264420
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.
    Eddleston JM; Pollard BJ; Blades JF; Doran B
    Intensive Care Med; 1995 Apr; 21(4):342-7. PubMed ID: 7650257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosage of antipseudomonal antibiotics in patients with acute kidney injury subjected to continuous renal replacement therapies].
    Carcelero San Martín E; Soy Muner D
    Med Intensiva; 2013 Apr; 37(3):185-200. PubMed ID: 22475763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives in the treatment of acute renal failure.
    Ronco C; Ghezzi P; Bellomo R; Brendolan A
    Blood Purif; 1999; 17(2-3):166-72. PubMed ID: 10449875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
    Pea F; Poz D; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ciprofloxacin in the treatment of hospital-acquired pneumonia: a surveillance study in 676 patients].
    Kljucar S; Rost KL; Landen H
    Pneumologie; 2002 Oct; 56(10):599-604. PubMed ID: 12375221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of serious infections with intravenous ciprofloxacin.
    Scully BE; Neu HC
    Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.
    Bellomo R; Tipping P; Boyce N
    Crit Care Med; 1993 Apr; 21(4):522-6. PubMed ID: 8472571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing hypothermia during continuous veno-venous haemodiafiltration: a randomized controlled trial.
    Rickard CM; Couchman BA; Hughes M; McGrail MR
    J Adv Nurs; 2004 Aug; 47(4):393-400. PubMed ID: 15271158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous veno-venous haemodiafiltration in an infant with a stage ivs neuroblastoma and acute renal failure.
    Hansen TG; Nielsen FT; Jepsen SB; Carlsen NL
    Acta Paediatr; 2000 Dec; 89(12):1500-1. PubMed ID: 11195246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.